fbpx

pharma & healthcare

FUTUREHEALTH: One-Year Anniversary

  • Posted: September 30, 2022

September 29, 2022 — FUTUREHEALTH: ONE-YEAR ANNIVERSARY

It’s the first anniversary of FutureHealth. To celebrate, we invited members of ARF’s Pharma Council to look back on our past episodes and reflect on what we learned and what surprised us. Bill Salokar, Vice President of Client Solutions at Skim, moderates the discussion.

A conversation with Tony Cregler, SVP and Strategy Director at Leo Burnett, Moffat Frazier, Senior Vice President and Managing Director at Data Insights & Solutions, Lori Holmes, a Partner at HawkPartners, Seth Duncan, Chief Data Officer at Real Chemistry, Kelly Lundquist, Senior Vice President and Head Of Health Strategy North America at Havas Media and Anshu Gupta Associate VP, Global Market Research at Eli Lilly And Company.

Pharma Council FutureHealth Podcast/Webcast Series: Trends in the Patient Journey: What to Expect in the Next 3-5 Years

  • Posted: September 28, 2022

November 25, 2021 – Episode 3:  The Omni Patient Journey: The Role of Self-Service in Healthcare Access, a conversation with Claire Kane, EVP and Director of Strategic Planning at Wunderman Thompson Health, moderated by Seth Duncan of Real Chemistry and Marjorie Reedy of Merck (Co-Chairs of the Pharma Council).

One of the most prominent issues of the 21st century is how to make healthcare more accessible, and the pandemic is arguably the tipping point. While it exposed the consequences of continued fragmentation, inequities and the rising costs of healthcare, it also demonstrated how it’s possible to make healthcare accessible to everyone, everywhere. In this episode, we look at how to expand this accessibility going forward by rethinking the patient journey and the role of health technology.

Pharma Council FutureHealth Podcast/Webcast Series: Trends in the Patient Journey: What to Expect in the Next 3-5 Years

  • Posted: September 28, 2022

January 27, 2021 — Episode 4: Looking into the Crystal Ball: The Future of Pharma Advertising Through Data-Driven Targeting, a conversation with Jen Werther, Chief Strategy Officer of DeepIntent, moderated by Moffat Frazier of Horizon Media and Seth Duncan of Real Chemistry (Co-Chair, Pharma Council).

Pharmaceutical and healthcare companies have increased digital advertising over the years, spending an estimated $11 billion on online marketing in 2021. They’re second only to retail when it comes to investing in these platforms. Data on individuals and healthcare providers are changing how the industry promotes products and care. An executive at one of the companies in the forefront of this change discusses how these data will have an impact on pharma marketing to both patients and providers in the future.

Pharma Council FutureHealth Podcast/Webcast Series: Trends in the Patient Journey: What to Expect in the Next 3-5 Years

  • Posted: September 28, 2022

February 27, 2022 — Episode 5: Visions for the Future of Patient Experiences in the Technoverse, a conversation with Dr. Maura Scott, the Persis E. Rockwood Professor of Marketing and Dr. Martin Mende, Jim Moran Professor of Business Administration. Both are from Florida State University’s College of Business.

COVID has impacted our lives in many ways, including increasing our reliance on technology. We now do virtually what we couldn’t do in person. In healthcare, virtual care for non-urgent visits not only increased but, according to a study by the Cleveland Clinic, most patients were happy with the results. This episode looks at how advances in technology can go beyond telehealth and explores visions for the future of the patient experience in the “technoverse” with two professors who have devoted years of study to its development,

Pharma Council FutureHealth Podcast/Webcast Series: Trends in the Patient Journey: What to Expect in the Next 3-5 Years

  • Posted: September 28, 2022

March 24, 2022 — Episode 6: Data Exhaust: What Health Signals are Being Generated Digitally and How Can We Use Them to Improve Outcomes , a conversation with Chris Neuner, Chief Strategy Officer at Pulsepoint Inc.

In this information age, patients are often surround by too much information. With the billions spent on digital ads, and amidst all the clutter, brands can find it challenging to connect to potential customers. The solution may lie in abilities to mine data. And how life science companies use data to coordinate communication and care with both patients and physicians. We cut through some of this clutter to look at data exhaust: what health signals are being generated digitally and how to use them to improve outcomes.

Pharma Council FutureHealth Podcast/Webcast Series: Trends in the Patient Journey: What to Expect in the Next 3-5 Years

  • Posted: September 28, 2022

April 28, 2022 — Episode 7: The Empowered Patient Journey (pt 1), a conversation with Nina Wachsman, CEO/Co-Founder of Know Rare.

Over the last couple of years, the pandemic has evoked massive disruption to all part of our lives, including our healthcare system, and this has drastically changed today’s patient journey. In the first of our two-part series, the Empowered Patient Journey, guest host Kelly Lundquist, Senior Vice President and Head Of Health Strategy North America at Havas Media, and CEO/Co-Founder of Know Rare Nina Wachsman discuss how the confluence of these behavioral changes by both patients and brands is giving rise to heightened patient expectations when it comes to healthcare.

Guest: Nina Wachsman, CEO/Co-Founder of Know Rare

For more information on Know Rare, check out our site: www.knowrare.com
To contact us please reach out to Liz Kay, Business Development and Partnerships: Liz@knowrare.com

Pharma Council FutureHealth Podcast/Webcast Series: Trends in the Patient Journey: What to Expect in the Next 3-5 Years

  • Posted: September 28, 2022

May 25, 2022 — Episode 8: The Empowered Patient Journey (pt 2), a conversation with Nina Wachsman, CEO/Co-Founder of Know Rare.

The COVID pandemic, which hit us in March 2020, has changed our lives in many ways, including how we deal with healthcare. In the second of our two-part series, the Empowered Patient Journey, guest host Kelly Lundquist, Senior Vice President and Head Of Health Strategy North America at Havas Media, interviews a panel of experts on how patients can navigate the complex healthcare system to find the right doctors, support groups and care that works for them.

Guests:
Nina Wachsman, CEO/Co-Founder of Know Rare
Rob Weker, patient and cancer survivor
Patrick Howie, Founder and CEO of MediFind

Pharma Council FutureHealth Podcast/Webcast Series: Trends in the Patient Journey: What to Expect in the Next 3-5 Years

  • Posted: September 28, 2022

June 30, 2022 — Episode 9: Four Tensions Driving the Future of Wellness, a conversation with, Matt Carmichael, Senior Vice President at Ipsos where he heads the Ipsos Trends and Foresight Lab, and Editor of Ipsos’ magazine, What the Future.

Some trends in health care grow out of Americans’ attitudes towards health and wellness. Ipsos, one of the world’s largest and most esteemed market research companies, has been monitoring these trends and attitudes. Those trends reveal occasional tensions between attitudes and our current health and wellness environment and between various sectors of the us population. Four of these tensions are outlined in an article in the latest issue of What the Future.

Pharma Council FutureHealth Podcast/Webcast Series: Trends in the Patient Journey: What to Expect in the Next 3-5 Years

  • Posted: September 28, 2022

July 28, 2022 — Episode 10: Patient Segmentation, a conversation with, Kelly Peters, Vice President of the Marketing Center of Excellence within IQVIA Commercial Solutions and Mandy Rexroat, Senior Vice President, Group Account Director at 21GRAMS, part of Real Chemistry

Patient segmentation is a process of dividing people with a particular health condition into groups based on their diagnosis, behavior, lifestyle, and needs. Guest host Anna Bradfield, ARF Pharma Council member and SVP Brand Strategy at Wunderman Thompson Health, leads our discussion of the benefits of patient segmentation and how it’s evolving.

 Next »